Outcome of the 8th CoC Meeting held on 15-05-2025
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Kobo Biotech Limited, currently under the Corporate Insolvency Resolution Process (CIRP), held its 8th meeting of the Committee of Creditors on 15 May 2025 in Mumbai. The company entered insolvency following an NCLT Hyderabad order dated 17 January 2025 in C.P.(IB) 277/7/HDB/2023, with a Resolution Professional already appointed. The meeting discussed progress on the resolution process, including sharing financial proposals with Resolution Applicants via a draft excel sheet circulated to CoC members on 17 May 2025. Notably, there were no voting items on the agenda, indicating the process is still in the evaluation and discussion phase rather than a decision-making stage.
The company remains in active insolvency proceedings with no resolution plan approved yet, which means equity shareholders continue to face significant uncertainty and likely dilution or wipeout of value. Routine CoC updates suggest the resolution process is ongoing, but the absence of any voting item signals no immediate decision on a revival or liquidation plan.